| Spanish Guidelines on Treatment of Bronchiectasis in Adults |
18 |
| Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults |
15 |
| Factors Affecting Lung Function: A Review of the Literature |
14 |
| Montelukast, Leukotriene Inhibitor, Reduces LPS-Induced Acute Lung Inflammation and Human Neutrophil Activation |
10 |
| Characteristics of COPD Patients Managed in Respiratory Medicine Departments in Spain, According to GOLD Groups and GesEPOC Clinical Phenotypes |
9 |
| Medical Care According to Risk Level and Adaptation to Spanish COPD Guidelines (Gesepoc): The Epoconsul Study |
8 |
| Neutrophil Count Percentage and Neutrophil-Lymphocyte Ratio as Prognostic Markers in Patients Hospitalized for Community-Acquired Pneumonia |
8 |
| Recommendations on non-Pharmacological Treatment in Chronic Obstructive Pulmonary Disease From the Spanish COPD Guidelines (GesEPOC 2017) |
7 |
| Prognostic Value of Frequent Exacerbations in Bronchiectasis: The Relationship With Disease Severity |
7 |
| Prevalence of COPD in 6 Urban Clusters in Argentina: The EPOC.AR Study |
6 |
| Patients with Chronic Obstructive Pulmonary Disease Exacerbations: Recommendations for Diagnosis, Treatment and Care |
6 |
| Impact of Self-Efficacy on The Quality of Life of Children With Asthma and Their Caregivers |
5 |
| Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Summary of Recommendations |
5 |
| The BIOMEPOC Project: Personalized Biomarkers and Clinical Profiles in Chronic Obstructive Pulmonary Disease |
5 |
| Use of Magnetic Resonance Imaging for N-Staging in Patients with Non-Small Cell Lung Cancer. A Systematic Review |
5 |
| 10 Years After EPISCAN: A New Study on the Prevalence of COPD in Spain - A Summary of the EPISCAN II Protocol |
5 |
| LncRNA MALAT1 Promotes Lung Cancer Proliferation and Gefitinib Resistance by Acting as a miR-200a Sponge |
4 |
| Silicosis in Artificial Quartz Conglomerate Workers |
4 |
| Alveolar and Bronchial Nitric Oxide in Chronic Obstructive Pulmonary Disease and Asthma-COPD Overlap |
4 |
| Results of the Andalusian Cystic Fibrosis Neonatal Screening Program, 5 Years After Implementation |
3 |
| Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) Population |
3 |
| Determinants of the Appearance and Progression of Early-Onset Chronic Obstructive Pulmonary Disease in Young Adults. A Case-Control Study with Follow-up |
3 |
| CT-guided Transthoracic Core-Needle Biopsies of Mediastinal and Lung Lesions in 235 Consecutive Patients: Factors Affecting the Risks of Complications and Occurrence of a Final Diagnosis of Malignancy |
3 |
| Home Non-Invasive Ventilation for COPD: How, Who and When? |
3 |
| Prevalence and Features of Asthma in Young Adults in Urban Areas of Argentina |
3 |
| Real-Life Experience with Pirfenidone in Idiopathic Pulmonary Fibrosis in Argentina. A Retrospective Multicenter Study |
3 |
| Official Statement of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) on Electronic Cigarettes and IQOS (R) |
3 |
| Diagnostic Accuracy of Pleural Fluid Adenosine Deaminase for Diagnosing Tuberculosis. Meta-analysis of Spanish Studies |
2 |
| Adherence to Long-Term Oxygen Therapy. Influence of Tobacco Use |
2 |
| Frequency of Osteoporosis and Vertebral Fractures in Chronic Obstructive Pulmonary Disease (COPD) Patients |
2 |
| Combined Hepatic and Pulmonary Metastasectomies From Colorectal Carcinoma. Data From the Prospective Spanish Registry 2008-2010 |
2 |
| Risk Of Recurrence After Withdrawal Of Anticoagulation In Patients With Unprovoked Venous Thromboembolism: External Validation Of The Vienna Nomogram And The Dash Prediction Score |
2 |
| Usefulness of The Piko-6 Portable Device for Early COPD Detection in Primary Care |
2 |
| The 6-Minute Walk Test as a Tool for Determining Exercise Capacity and Prognosis in Patients with Silicosis |
2 |
| Esculetin Attenuates the Growth of Lung Cancer by Downregulating Wnt Targeted Genes and Suppressing NF-kappa B |
2 |
| New Perspectives in Oxygen Therapy Titration: Is Automatic Titration the Future? |
2 |
| Bioengineered Lungs: A Challenge and An Opportunity |
2 |
| Prognostic Validation Using GesEPOC 2017 Severity Criteria |
2 |
| Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience |
2 |
| Physical Activity Program Improves Functional Exercise Capacity and Flexibility in Extremely Preterm Children With Bronchopulmonary Dysplasia Aged 4-6 Years: A Randomized Controlled Trial |
2 |
| Asthma, rhinitis, and nasal polyp multimorbidities |
2 |
| Translation and Validation of the Multidimensional Dyspnea-12 Questionnaire |
2 |
| Translation to Spanish and Validation of the Specific Saint George's Questionnaire for Idiopathic Pulmonary Fibrosis |
2 |
| Description and Survival of Stage I and II Lung Cancer Patients |
2 |
| Bronchiectasis: A Complex, Heterogeneous Disease |
1 |
| Acute Exacerbation According to GOLD 2017 Categories in Patients with Chronic Obstructive Pulmonary Disease |
1 |
| The Future of TB Resistance Diagnosis: The Essentials on Whole Genome Sequencing and Rapid Testing Methods |
1 |
| The MEGA Project: A Study of the Mechanisms Involved in the Genesis and Disease Course of Asthma. Asthma Cohort Creation and Long-Term Follow-Up |
1 |
| Rationale and Methodology of the SARAH Trial: Long-Term Cardiovascular Outcomes in Patients With Resistant Hypertension and Obstructive Sleep Apnea |
1 |
| Screening for Latent Tuberculosis Infection in Patients who are Candidate for Biological Therapies in Spain? A Multidisciplinary Survey |
1 |
